A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC
Clinical trial NCT05849298 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05849298
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-03
- Primary completion
- 2026-12-23
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.